Endometrial intraepithelial neoplasia: A new standard for diagnosing precancers

Contemporary Ob-Gyn

Volumn 46, Issue 5, 2001, Pages 92-98

  Mutter, George L ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0009167635     PISSN: 00903159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Mutter GL, Chaponot ML, Fletcher JA. A polymerase chain reaction assay for non-random X chromosome inactivation identifies monoclonal endometrial cancers and precancers. Am J Pathol. 1995;146:501-508.
2. Mutter GL, Boynton KA, Faquin WC, et al. Allelotype mapping of unstable microsatellites establishes direct lineage continuity between endometrial precancers and cancer. Cancer Res. 1996;56:4483-4486.
3. Mutter GL, Baak JP, Crum CP, et al, Endometrial precancer diagnosis by histopathology, clonal analysis, and computerized morphometry. J Pathol. 2000;190:462-469.
4. Enomoto T, Haba T, Fujita M, et al. Clonal analysis of high-grade squamous intraepithelial lesions of the uterine cervix. Int J Cancer. 1997;73:339-344.
5. Park TW, Richart RM, Sun XW, et al. Association between human papillomavirus type and clonal status of cervical squamous intraepithelial lesions. J Natl Cancer Inst. 1996;88:355-358.
6. Tate JE, Mutter GL, Boynton KA, et al. Monoclonal origin of vulvar intraepithelial neoplasia and some vulvar hyperplasias. Am J Pathol. 1997;150:315-322.
7. Bedi G, Westra W, Gabrielson E, et al. Multiple head and neck tumors: evidence for a common clonal origin. Cancer Res. 1996;56:2484-2487.
8. Mao L, Schoenberg MP, Scicchitano M, et al. Molecular detection of primary bladder cancer by microsatellite analysis. Science. 1996;271:659-662.
9. Ziegler A, Jonason A, Leffell D, et al. Sunburn and p53 in the onset of skin cancer. Nature. 1994;372:773-776.
10. Zhuang Z, Vortmeyer AO, Mark EJ, et al. Barren's esophagus: metaplastic cells with loss of heterozygosity at the APC gene locus are clonal precursors to invasive adenocarcinoma. Cancer Res. 1996;56:1961-1964.
11. Mutter GL, Lin MC, Fitzgerald JT, et al. Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers. J Natl Cancer Inst. 2000;92:924-930.
12. Mutter GL, Wada H, Faquin WC, et al. K-ras mutations appear in the premalignant phase of both microsatellite stable and unstable endometrial carcino-genesis. Mol Pathol. 1999;52:257-262.
13. Mutter GL, Lin MC, Fitzgerald JT. et al. Changes in endometrial PTEN expression throughout the human menstrual cycle. J Clin Endorinol Metab. 2000;85:2334-2338.
14. Mutter GL. Endometrial intraepithelial neoplasia (EIN): will it bring order to chaos? The Endometrial Collaborative Group. Gynecol Oncol. 2000;76:287-290.
15. Mutter GL. Histopathology of genetically defined endometrial precancers. Int J Gynecol Pathol. 2000;19:301-309.
16. Orbo A, Baak JP, Kleivan I, et al. Computerized morpho-metrical analysis in endometrial hyperplasia for the prediction of cancer development A long-term retrospective study from northern Norway. J Clin Pathal. 2000;53:697-703.
17. Dunton CJ, Baak JP, Palazzo JP, et al. Use of computerized morphometric analyses of endometrial hyperplasias in the prediction of coexistent cancer. Am J Obstet Gynecol. 1996;174:1518-1521.
18. Baak JP, Nauta JJ, Wisse-Brekelmans EC, et al. Architectural and nuclear morphometrical features together are more important prognosticators in endometrial hyperplasias than nuclear morphometrical features alone. J Pathol. 1988;154:335-341.
19. Esteller M, Garcia A, Martinez-Palones JM, et al, Detection of clonality and genetic alterations in endometrial pipelle biopsy and its surgical specimen counterpart. Lab invest 1997;76:109-116.
20. Jovanovic AS, Boynton KA, Mutter GL. Uteri of women with endometrial carcinoma contain a histopathological spectrum of monoclonal putative precancers, some with microsatellite instability. Cancer Res. 1996;56:1917-1921.
21. Levine RL, Cargile CB, Blazes MS, et al. PTEN mutations and microsatellite instability in complex atypical hyperplasia, a precursor lesion to uterine endometrioid carcinoma. Cancer Res. 1998;58:3254-3258.
22. Maxwell GL, Risinger JI. Gumbs C, et al. Mutation of the PTEN tumor suppressor gene in endometrial hyperplasias. Cancer Res. 1998;58:2500-2503.
23. Duggan BD, Felix JC, Muderspach LI, et al. Early mutational activation of the c-Ki-ras oncogene in endometrial carcinoma. Cancer Res. 1994;54:1604-1607.
24. Sasaki H, Nishii H, Takahashi H, et al. Mutation of the Ki-ras protooncogene in human endometrial hyperplasia and carcinoma. Cancer Res. 1993;53:1906-1910.
25. Esteller M, Catasus L, Matias-Guiu X, Mutter GL, et al. hMLH1 promoter hypermethylation is an early event in human endometrial tumorigenesis. Am J Pathol. 1999;155:1767-1772.
26. Stambolic V, Tsao MS, Macpherson D, et al. High incidence of breast and endometrial neoplasia resembling human Cowden syndrome in pten+/- mice. Cancer Res. 2000;60:3605-3611.
27. Faquin WC, Fitzgerald JT, Boynton KA, Mutter GL. Intratumoral genetic heterogeneity and progression of endometrioid type endometrial adenocarcinomas. Gynecol Oncol. 2000;78:152-157.
28. Scully RE, Bonfiglio TA, Kurman RJ, et al. Uterine corpus. Histological Typing of Female Genital Tract Tumors. New York, NY: Springer-Verlag; 1994:13-31.
29. Kendall BS, Ronnett BM, Isacson C, et al. Reproducibility of the diagnosis of endometrial hyperplasia, atypical hyperplasia, and well-differentiated carcinoma. Am J Surg Pathol. 1998;22:1012-1019.
30. Bergeron C, Nogales FF, Masseroli M, et al. A multicentric European study testing the reproducibility of the WHO Classification of endometrial hyperplasia with a proposal of a simplified working classification for biopsy and curettage specimens. Am J Surg Pathol. 1999;23:1102-1108.
31. Mutter GL, Ince TA, Baak JP, et al. Molecular identification of latent precancers in histologically normal endometrium. Cancer Res. In press.